elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33373434-B5C5EE4E-E969-4C81-B1E4-A7C4E5303169
Q33373434-B5C5EE4E-E969-4C81-B1E4-A7C4E5303169
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33373434-B5C5EE4E-E969-4C81-B1E4-A7C4E5303169
Phase II study of cisplatin plus epirubicin salvage chemotherapy in refractory germ cell tumors.
P921
Q33373434-B5C5EE4E-E969-4C81-B1E4-A7C4E5303169
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33373434-B5C5EE4E-E969-4C81-B1E4-A7C4E5303169
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
82630af7e1151e88e8ae34ab9d05aea66cb2f3b3
P921
chemotherapy